Kedrion Biopharma brought new scientific insights, expert-led discussions, and rare disease scientific discussions to the 34th International Society on Thrombosis and Haemostasis (ISTH) Congress in Paris, contributing to ongoing efforts to improve outcomes for patients. “Scientific leadership is an essential part of how we deliver for patients,” said Bob Rossilli, Chief Commercial Officer, Kedrion Biopharma.